Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Papay

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Neurology|January 9, 2013
Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control studyDaniel Weintraub, Kimberly Papay, Andrew Siderowf, et al.
Neurology|October 19, 2013
Author responseDaniel Weintraub, Andrew Siderowf, Kimberly Papay
Neurology|May 21, 2015
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyDaniel Weintraub, Kimberly Papay, Sharon X Xie
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2011
Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating ScaleDaniel Weintraub, Eugenia Mamikonyan, Kimberly Papay, et al.
Neurology|July 20, 2014
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyKimberly Papay, Sharon X Xie, Matthew Stern, et al.
Psycho-Oncology|January 5, 2023
CancerSupportSource<sup>TM</sup> -Caregiver: Development of a distress screening measure for cancer caregiversAlexandra K Zaleta, Melissa F Miller, Erica E Fortune, et al.
Parkinsonism & Related Disorders|December 28, 2010
Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variabilityKimberly Papay, Eugenia Mamikonyan, Andrew D Siderowf, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Neurology|January 9, 2013
Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control studyDaniel Weintraub, Kimberly Papay, Andrew Siderowf, et al.
Neurology|October 19, 2013
Author responseDaniel Weintraub, Andrew Siderowf, Kimberly Papay
Neurology|May 21, 2015
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyDaniel Weintraub, Kimberly Papay, Sharon X Xie
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2011
Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating ScaleDaniel Weintraub, Eugenia Mamikonyan, Kimberly Papay, et al.
Neurology|July 20, 2014
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyKimberly Papay, Sharon X Xie, Matthew Stern, et al.
Psycho-Oncology|January 5, 2023
CancerSupportSource<sup>TM</sup> -Caregiver: Development of a distress screening measure for cancer caregiversAlexandra K Zaleta, Melissa F Miller, Erica E Fortune, et al.
Parkinsonism & Related Disorders|December 28, 2010
Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variabilityKimberly Papay, Eugenia Mamikonyan, Andrew D Siderowf, et al.
Pageof 1